A promising mRNA vaccine for neovascular eye diseases (IMAGE)
Caption
Researchers at Science Tokyo developed an mRNA vaccine that suppressed abnormal retinal blood vessel growth in mouse models. The vaccine can be administered intramuscularly and showed effectiveness comparable to current eye injection therapies, while offering a less invasive alternative.
Credit
Institute of Science Tokyo
Usage Restrictions
For use in scientific news only. Attribution is required. The image may not be modified in ways that alter its meaning or context.
License
Original content